search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
P RODUCT S


Medical trays supplied for UK vaccination programme


WARWICK SASCO is supplying 40,000 medical trays to the NHS for use in the vaccination programme against Coronavirus. The firm’s tray was used during the historic moment that 90-year-old Margaret Keenan received the first vaccination in the UK at University Hospital Coventry and Warwick- shire. Warwick SASCo produces a range of products for use in the medical sector from kidney dishes and gallipots through to instru- ment trays and instrument protection and transportation units. The company’s products also include bed pans and urinal bottles, all of which are made by suppliers in the UK, particularly in the West Midlands. It’s not the first time the firm has been part of the fight against COVID-19 having answered a call to supply the Nightingale Hospitals at the start of the crisis. Now its trays are being sent to a distribution hub in Coventry and, from


Investment in pre-fillable syringes


there, will go to vaccination points all over the country.


Managing director, Darby Booth, said: “It was a wonderful moment for everyone to see the first vaccination against COVID-19 being administered here in the UK after such a difficult period. And, of course, it was a very proud moment for us, as a business, to see one of our products being beamed all over the world as it was used in that very first vaccination. We are very pleased to be playing our part.”


Effective disinfectants to tackle COVID-19


PDI is following all developments surround- ing the 2019 Novel Coronavirus (2019- nCoV). Coronaviruses (CoVs) are enveloped viruses, which means they are held within a lipid envelope. Despite the serious nature of the disease some of these enveloped viruses


can cause, they are easily compromised by most disinfectants. PDI offers several surface disinfectant products with proven efficacy to European Norm EN 14476 for enveloped viruses. The following products are effective against Coronavirus: Sani-Cloth Chlor, Sani-Cloth AF Universal, Super Sani-Cloth Plus, Sani-Cloth 70 and Sani-Cloth Active. It is important to ensure the surface remains wet for the required contact time to allow the disinfectant to work. PDI Sani-Cloth Chlor has been tested to Human Coronavirus EPA to a contact time of one minute. PDI Sani-Cloth AF Universal, Sani-Cloth 70 and Super Sani-Cloth Plus are effective against enveloped viruses in just 30 seconds of contact time or less. PDI Sani- Cloth Active is effective against enveloped viruses tested to DVV/RKI in just 30 seconds.


Pre-packed surgical retractor kits


JUNE MEDICAL has launched a new range of pre-packed retractor kits especially for male procedures. The Galaxy II Male kit is set to advance male procedures by dramatically improving visualisation during surgery. The easy-to-use kit is suitable for a wide range of procedures requiring optimal control over the surgical site, such as scrotal and associated surgeries, as well as prosthetic testicle implantations. The kit features a number of different accessories and a novel hammock elevation strap to manoeuvre the


male anatomy, allowing the penis to be held securely without requiring hooks through the skin, improving patient comfort. The retractor’s cam locks allow simple single- handed adjustment for rapid re-positioning, while the slots on the retractor ring easily secure the stays in place. Together with a range of stay hooks designed to enable high tension without the risk of tissue tearing, this system provides a cost-effective and convenient solution for a wide range of surgical procedures.


78 l WWW.CLINICALSERVICESJOURNAL.COM


BD has announced plans to invest approximately $1.2 billion over a four- year period to expand and upgrade manufacturing capacity and technology for pre-fillable syringes (PFS) and advanced drug delivery systems (ADDS) across its six global manufacturing locations and add a new manufacturing facility in Europe. The investment will also fund capacity expansion, new product innovations and manufacturing technology enhancements across its existing network, all designed to maximise supply and reduce risks for pharmaceutical companies that rely on ready-to-fill syringes for their injectable drugs – including complex biologics, vaccines and small molecules. This investment positions BD to have the needed surge capacity for increased pre-fillable syringe demand during times of pandemic response.


Faecal calprotectin testing solution


Faecal calprotectin testing is helping to improve patient care and save money for the NHS by preventing the need for unnecessary endoscopy procedures for many patients. Through a convenient, simple point-of-care or laboratory test, it helps to screen out people with Irritable Bowel Syndrome (IBS) from those with Inflammatory Bowel Disease (IBD). ALPHA LABORATORIES has worked in


partnership with clinics and laboratories over many years to champion calprotectin testing. The extensive range of standardised assays from BÜHLMANN, provides solutions for improved patient care and management in both screening and monitoring applications. Across the full range of assays the quantitative results are standardised and scalable from near patient testing to automated laboratory applications. The Calex enables quick, easy and consistent sample extraction improving workflow within the laboratory with direct loading onto analysers. For known IBD patients, IBDoc provides the privacy and convenience to help manage their condition from home and reduce hospital appointments.


JANUARY 2021


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80